Financings in Brief: Biogen
This article was originally published in The Gray Sheet
Executive Summary
Biogen: Biotech firm says it will repurchase up to 2.5 mil. shares of common stock "from time to time over the next two years, depending on market conditions." The repurchased shares will be used "for general corporate purposes, such as stock to be issued under employee stock option and stock purchase plans," Biogen notes...